Ameriprise
TMDX icon

Ameriprise’s Transmedics TMDX Stock Holding History

Ameriprise’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.31M Sell
79,948
-24,766
-24% -$2.1M ﹤0.01% 2508
2026
Q1 		$10.4M Sell
104,714
-19,625
-16% -$2.56M ﹤0.01% 1902
2025
Q4 		$15.1M Buy
124,339
+9,549
+8% +$1.2M ﹤0.01% 1615
2025
Q3 		$12.9M Buy
114,790
+12,699
+12% +$1.49M ﹤0.01% 1719
2025
Q2 		$13.7M Buy
102,091
+3,333
+3% +$366K ﹤0.01% 1593
2025
Q1 		$6.64M Buy
98,758
+873
+0.9% +$60K ﹤0.01% 2089
2024
Q4 		$6.1M Sell
97,885
-24,717
-20% -$2.3M ﹤0.01% 2214
2024
Q3 		$19.2M Buy
122,602
+64,866
+112% +$9.99M ﹤0.01% 1351
2024
Q2 		$8.7M Sell
57,736
-47,846
-45% -$5.74M ﹤0.01% 1868
2024
Q1 		$7.81M Sell
105,582
-29,340
-22% -$2.42M ﹤0.01% 2014
2023
Q4 		$10.6M Sell
134,922
-827
-0.6% -$49.9K ﹤0.01% 1726
2023
Q3 		$7.43M Sell
135,749
-22,354
-14% -$1.61M ﹤0.01% 1948
2023
Q2 		$13.3M Buy
158,103
+18,412
+13% +$1.41M ﹤0.01% 1548
2023
Q1 		$10.6M Buy
139,691
+12,740
+10% +$881K ﹤0.01% 1728
2022
Q4 		$7.84M Buy
126,951
+55,299
+77% +$2.94M ﹤0.01% 1951
2022
Q3 		$2.99M Buy
+71,652
New +$3.12M ﹤0.01% 2576
2021
Q4 		– Sell
-6,037
Closed -$200K – 4048
2021
Q3 		$200K Sell
6,037
-475
-7% -$14.5K ﹤0.01% 3705
2021
Q2 		$216K Sell
6,512
-5,245
-45% -$145K ﹤0.01% 3735
2021
Q1 		$488K Buy
+11,757
New +$362K ﹤0.01% 3414

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Ameriprise's TMDX Position: Q2 2026 in Review

Ameriprise reduced its Transmedics (TMDX) stake by 24% in Q2 2026, selling an estimated $2.1M and leaving 79,948 shares worth $5.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2508.

Ameriprise first reported a position in TMDX in Q1 2021 and has held it in 19 quarters since. The position peaked at $19.2M in Q3 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Ameriprise held 79,948 shares of Transmedics worth $5.31M as of Q2 2026.
  • Ameriprise sold 24,766 Transmedics shares in Q2 2026, an estimated $2.1M.
  • Transmedics made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2508 holding.
  • Ameriprise first reported a position in Transmedics in Q1 2021 and has held it in 19 quarters since.
  • Ameriprise's Transmedics position peaked at $19.2M in Q3 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.